Literature DB >> 21918495

Million hearts: strategies to reduce the prevalence of leading cardiovascular disease risk factors--United States, 2011.

.   

Abstract

Cardiovascular disease (CVD) causes one in three (approximately 800,000) deaths reported each year in the United States. Annual direct and overall costs resulting from CVD are estimated at $273 billion and $444 billion, respectively. Strategies that address leading CVD risk factors, such as hypertension, high cholesterol levels, and smoking, can greatly reduce the burden of CVD. To estimate the U.S. prevalence of these three risk factors, CDC analyzed data from the National Health and Nutrition Examination Survey (NHANES) on uncontrolled hypertension, uncontrolled high levels of low-density lipoprotein cholesterol (LDL-C), and current smoking. This report summarizes the results of that analysis, which found that 49.7% of U.S. adults aged ≥20 years (an estimated 107.3 million persons) have at least one of the three risk factors. To reduce the prevalence of CVD risk factors among persons in the United States, the U.S. Department of Health and Human Services, in collaboration with nonprofit and private organizations, is launching Million Hearts, a multifaceted combination of evidence-based interventions and strategies aimed at preventing 1 million heart attacks and strokes over the next 5 years.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21918495

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  56 in total

Review 1.  Public health options for improving cardiovascular health among older Americans.

Authors:  Kurt J Greenlund; Nora L Keenan; Paula F Clayton; Dilip K Pandey; Yuling Hong
Journal:  Am J Public Health       Date:  2012-06-14       Impact factor: 9.308

2.  Geographic Variation in Trends and Disparities in Acute Myocardial Infarction Hospitalization and Mortality by Income Levels, 1999-2013.

Authors:  Erica S Spatz; Adam L Beckman; Yun Wang; Nihar R Desai; Harlan M Krumholz
Journal:  JAMA Cardiol       Date:  2016-06-01       Impact factor: 14.676

Review 3.  Management of depression after myocardial infarction.

Authors:  Peter A Shapiro
Journal:  Curr Cardiol Rep       Date:  2015-10       Impact factor: 2.931

4.  The Role of Hypertension in Race-Ethnic Disparities in Cardiovascular Disease.

Authors:  Pelbreton C Balfour; Carlos J Rodriguez; Keith C Ferdinand
Journal:  Curr Cardiovasc Risk Rep       Date:  2015-04

Review 5.  Hypertension in African Americans.

Authors:  Nomsa Musemwa; Crystal A Gadegbeku
Journal:  Curr Cardiol Rep       Date:  2017-10-28       Impact factor: 2.931

Review 6.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

7.  We Can Save a Million Hearts.

Authors:  Thomas E Kottke; Sarah Horst
Journal:  Perm J       Date:  2019-06-14

8.  Collection and laboratory methods for dried blood spots for hemoglobin A1c and total and high-density lipoprotein cholesterol in population-based surveys.

Authors:  Ivey M Miller; David A Lacher; Te-Ching Chen; George W Zipf; Renee M Gindi; Adena M Galinsky; Tatiana Nwankwo; Ana L Terry
Journal:  Clin Chim Acta       Date:  2015-03-27       Impact factor: 3.786

9.  Million hearts--where population health and clinical practice intersect.

Authors:  Janet S Wright; Hilary K Wall; Peter A Briss; Michael Schooley
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-07-01

10.  Pilot trial of a licensed practical nurse intervention for hypertension and depression.

Authors:  Hillary R Bogner; Heather F de Vries; Elise M Kaye; Knashawn H Morales
Journal:  Fam Med       Date:  2013-05       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.